Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Invokana
Invokana
J&J's Invokana continues downward market-share spiral as Lilly, BI's Jardiance advances
Fierce Pharma
Wed, 07/19/17 - 07:47 pm
JNJ
Invokana
Eli Lilly
Boehringer Ingelheim
Jardiance
diabetes
For diabetes drugs, lowering blood sugar may no longer be enough to stay competitive
Medical Marketing and Media
Thu, 06/22/17 - 09:32 am
diabetes
blood sugar
competition
Novo Nordisk
Victoza
Eli Lilly
Jardiance
Invokana
JNJ
AstraZeneca, Boehringer cry 'no class effect' after Johnson & Johnson's Invokana doubles amputations in study
Fierce Pharma
Wed, 06/14/17 - 09:00 pm
AstraZeneca
Boehringer Ingelheim
JNJ
Invokana
diabetes
Jardiance
amputation
J&J's Invokana lowers CV risk, but by enough to compete?
BioPharma Dive
Wed, 06/14/17 - 11:37 am
JNJ
Invokana
diabetes
Jardiance
Eli Lilly
Boehringer Ingelheim
ADA: Merck, Pfizer notch success, but late with SGLT-2 data
BioPharma Dive
Tue, 06/13/17 - 12:15 pm
diabetes
Merck
Pfizer
SGLT2 inhibitor
Januvia
Invokana
Farxiga
Jardiance
Eli Lilly
Boehringer Ingelheim
AstraZeneca
JNJ
J&J Drug Prevents Heart Attacks At Cost Of Amputated Toes
Forbes
Mon, 06/12/17 - 10:15 pm
JNJ
heart attacks
Invokana
diabetes
amputation. Eli Lilly
Boehringer Ingelheim
Jardiance
Top 10 diabetes drugs by 2016 sales
Fierce Pharma
Thu, 06/8/17 - 10:04 am
diabetes
Sanofi
Novo Nordisk
Eli Lilly
Merck
Lantus
Januvia
Victoza
Levemir
Humalog
Novolog
Invokana
Johnson & Johnson's Analyst Day Was Overshadowed by This Worrisome Data
Motley Fool
Tue, 05/30/17 - 10:05 am
JNJ
Invokana
type 2 diabetes
FDA Adds Boxed Warning to Janssen's Type 2 Diabetes Drug Label
RAPS.org
Tue, 05/16/17 - 10:48 pm
FDA
Janssen
type 2 diabetes
warnings
Invokana
Invokamet
Diabetes meds from AZ, J&J and Lilly sharply cut death rates in real-world analysis
Fierce Pharma
Mon, 03/20/17 - 10:57 am
AstraZeneca
JNJ
Eli Lilly
Boehringer Ingelheim
diabetes
Farixga
Invokana
Jardiance
SGLT2 inhibitor
Merck and Pfizer prep for battle with SGLT2, combo diabetes filings
Fierce Pharma
Mon, 03/13/17 - 10:18 am
Merck
Pfizer
SGLT2 inhibitor
diabetes
ertugliflozin
Jardiance
Boehringer Ingelheim
Eli Lilly
JNJ
Invokana
AstraZeneca
Farxiga
FDA warns of kidney risks for diabetes drugs from Janssen, AstraZeneca
BioPharma Dive
Tue, 06/14/16 - 07:27 pm
FDA
diabetes
Janssen
JNJ
AstraZeneca
Farxiga
Invokana
J&J's Invokana shines in PhII Type 1 diabetes study--but raises the risk of serious side effects, too
Fierce Pharma
Mon, 06/13/16 - 07:10 pm
JNJ
Invokana
type 1 diabetes
Janssen
Diabetes Drug Shakeup: What You Need to Know About New FDA Warnings
Motley Fool
Tue, 04/19/16 - 09:50 am
FDA
diabetes
AstraZeneca
Takeda
Nesina
Onglyza
Eli Lilly
JNJ
Trajenta
Jardiance
Invokana
4 Reasons Why Johnson & Johnson Exploded Higher Following Its Q4 Earnings Release
Motley Fool
Thu, 01/28/16 - 09:02 pm
JNJ
earnings
Imbruvica
Invokana
Johnson & Johnson's Newest Billion-Dollar Blockbuster
Motley Fool
Thu, 01/28/16 - 08:58 am
JNJ
diabetes
Invokana
4 Blockbuster Drugs Whose Sales Could Easily Double
Motley Fool
Mon, 10/26/15 - 08:46 am
Xtandi
Medivation
Astellas
Eliquis
Pfizer
Bristol-Myers Squibb
Revlimid
Celgene
Invokana
JNJ
AbbVie's Humira, J&J's Invokana lead September's $231M in pharma TV ad spending
Fierce Pharma Marketing
Wed, 10/14/15 - 11:16 am
AbbVie
Humira
JNJ
Invokana
drug ads
J&J says its diabetes drug should have same survival edge as Lilly's
Yahoo/Reuters
Tue, 10/13/15 - 06:15 pm
JNJ
diabetes
Invokana
Jardiance
J&J says Jardiance survival benefit likely to be seen by Invokana
Yahoo/Reuters
Tue, 10/13/15 - 12:13 pm
JNJ
Jardiance
diabetes
Invokana
Pages
« first
‹ previous
1
2
3
4
next ›
last »